MSACL
MSACL

MSACL - The Association for Mass Spectrometry & Advances in the Clinical Lab

MSACL is committed to the advancement of mass spectrometry and other advanced technologies, including data science, in the clinical laboratory through education and training of practitioners, physicians, laboratory scientists, industrial scientists, and health care professionals involved in patient care and management. MSACL supports the development of new technologies to be used in laboratory medicine; including diagnosis, treatment, and prognosis of clinical disorders.

MSACL was incorporated in May 2009 as non-profit and is tax exempt under 501(c)(3). The association's mission is to further the accumulation and sharing of expertise in the area of mass spectrometry and advanced technologies for use in the clinical laboratory with the goal of improving patient care. As part of this mission the association hosts MSACL conferences in the US and Europe, as well as supporting educational activities in Asia. MSACL also supports and manages the society's Journal of Mass Spectrometry & Advances in the Clinical Lab.

Objectives & Target Audience

The objective of MSACL is to support the enhancement of patient care using technology & data science. The target audience includes pathologists, clinical laboratory directors, clinical scientists, and researchers, as well as laboratory diagnostic providers. This programs provided by MSACL are beneficial to healthcare administrators, laboratory quality control and standards scientists, as well as those responsible for implementation of clinical analyses for emergency response due to terrorism or accident.

Future Events

MSACL 2024

Monterey : March 17-22, 2024

MSACL - MSACL 2024 flyerMSACL - MSACL 2024 flyer

MSACL 2025-27

  • MSACL 2025 Montreal | September 21 - 26, 2025
  • MSACL 2026 Montreal | October 4 - 9, 2026
  • MSACL 2027 Montreal | September 26 - October 01, 2027

After 14 conferences on the West Coast of the United States, MSACL is moving east. To Montreal.

Past Events

  • MSACL 2023
  • MSACL 2022
  • MSACL 2021 EU
  • MSACLx 2020 Saint Malo
  • MSACL 2020 US
  • MSACL 2019 EU
  • MSACL 2019 US
  • MSACL 2018 EU
  • MSACL 2018 US
  • MSACL 2017 EU
  • MSACL 2017 US
  • MSACL 2016 EU
  • MSACL 2016 US
  • MSACL 2015 EU
  • MSACL 2015 US
  • MSACL 2014 EU
  • MSACL 2014 US
  • MSACL 2013
  • MBDxA 2013
  • MSACL 2012
  • MSACL 2011
  • MSACL 2010
  • MSACL 2008
  • Asilomar 2007
 

Wrote about us

Breaking Sensitivity Barriers: How MS³ is Transforming Biomarker Discovery for ALS and Beyond
Article | Science and research

Breaking Sensitivity Barriers: How MS³ is Transforming Biomarker Discovery for ALS and Beyond

Mayo Clinic researchers show how Orbitrap Astral discovery and Stellar MS³ validation improve sensitivity for detecting ALS biomarkers in extracellular vesicles.
Accelerating Biomarker Discovery and Validation: From Discovery to Clinical Utility
Article | Science and research

Accelerating Biomarker Discovery and Validation: From Discovery to Clinical Utility

Thermo Fisher Scientific’s MSACL 2025 workshop showcased how automation, proteomics, and mass spectrometry accelerate biomarker discovery, verification, and clinical validation.
 

Library

Open paper Development of the Comprehensive Method for Steroid Analysis by GCxGC-HR-TOFMS

Development of the Comprehensive Method for Steroid Analysis by GCxGC-HR-TOFMS

Instrumentation
GCxGC, GC/MSD, GC/HRMS, Sample Preparation, GC/TOF
Manufacturer
Agilent Technologies, GERSTEL, LECO
Industries
Clinical Research
Open paper Novel ion source with integrated separation column and replaceable emitters facilitates high-throughput multiplexed analysis

Novel ion source with integrated separation column and replaceable emitters facilitates high-throughput multiplexed analysis

Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Pharma & Biopharma, Proteomics
Open paper Highly multiplex targeted proteomics assay in plasma using the Stellar mass spectrometer with adaptive RT

Highly multiplex targeted proteomics assay in plasma using the Stellar mass spectrometer with adaptive RT

Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Proteomics , Clinical Research
Open paper Enhanced sensitivity of the Orbitrap Astral Zoom mass spectrometer for deeper proteome coverage in single-cell proteomics applications

Enhanced sensitivity of the Orbitrap Astral Zoom mass spectrometer for deeper proteome coverage in single-cell proteomics applications

Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Proteomics